Swapna Shanbhag

About

Swapna Shanbhag is a consultant ophthalmologist at the MaxiVision Super Speciality Eye Hospital in Hyderabad. After finishing her ophthalmology residency, she completed a two year fellowship in Cornea and Anterior segment at LVPEI, Hyderabad and then pursued a two year research fellowship in Ocular Surface diseases (ocular chemical burns/SJS) at Massachusetts Eye and Ear affiliated to Harvard University, Boston, USA. She then worked for 7 years as a Consultant Ophthalmologist in the Cornea department at the L.V. Prasad Eye Institute, Hyderabad.

Her main areas of clinical interest include cataract surgeries, corneal transplants (PK/DALK/DSAEK), surgeries involving stem cells of the cornea (SLET), artificial corneal transplantation (keratoprosthesis), and ocular surface reconstruction. Her research focuses on reducing the incidence and morbidity related to corneal blindness secondary to corneal chemical burns and Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN). She has published her research in international journals and has also presented at national and international meetings and has won awards for her research. She is also a member of the American Academy of Ophthalmology (AAO) and the Association for Research in Vision and Ophthalmology (ARVO). She also serves on the editorial board of the Indian Journal of Ophthalmology and BMC Ophthalmology.

Employment

• Maxivision Super Speciality Eye Hospital Consultant Ophthalmologist
  2026 - Present
• L.V. Prasad Eye Institute Consultant cornea surgeon
  2018 - 2025

Education

• Massachusetts Eye and Ear Infirmary Post-doctoral research fellowship in Cornea and Ocular Surface
  2016 - 2018
• L.V. Prasad Eye Institute Fellowship in Cornea and Ocular Surface
  2014 - 2016

Projects & Funding

Projects & funding information is unavailable.

Publications (108)

• Comparing Global Operating Room Waste Generated From Cataract, Corneal, and Conjunctival Surgeries
  Cornea 2026 DOI: 10.1097/ico.0000000000004226
  +Save
• Immunological Interplay at the Ocular Surface of Stevens-Johnson Syndrome, Ocular Cicatricial Pemphigoid, and Ocular Graft Versus Host Disease
  Investigative Ophthalmology & Visual Science 2026 DOI: 10.1167/iovs.67.6.26
  +Save
• Long-term Clinical Outcomes of Type 1 Keratoprosthesis: A 10-Year Experience
  Cornea 2026 DOI: 10.1097/ico.0000000000004149
  +Save
• Specificity of direct immunofluorescence in healthy conjunctival specimens
  The Ocular Surface 2025 DOI: 10.1016/j.jtos.2025.06.003
  +Save
• Preservative Related Ocular Surface Toxicity and the Need for Preservative Free Eye Drops in Ocular Surface Disorders - Recommendations of an Expert Group
  Seminars in Ophthalmology 2025 DOI: 10.1080/08820538.2025.2555903
  +Save
• Outcomes of Collagen Crosslinking in Patients with Keratoconus and Co-Existent Limbal Stem Cell Deficiency
  Clinical Ophthalmology 2025 DOI: 10.2147/opth.s548579
  +Save
• HLA-B Alleles With Shared Peptide Binding Specificities Define Global Risk of Co-trimoxazole-Induced Severe Cutaneous Adverse Drug Reactions
  The Journal of Allergy and Clinical Immunology: In Practice 2025 DOI: 10.1016/j.jaip.2025.08.001
  +Save
• Symblepharon: A Review of Etiology, Clinical Features, and Management Strategies
  Seminars in Ophthalmology 2025 DOI: 10.1080/08820538.2025.2519050
  +Save
• Adnexal surgeries in eyes with keratoprosthesis: challenges and long-term outcomes
  Orbit 2025 DOI: 10.1080/01676830.2025.2509237
  +Save
• HLA-B Alleles with Shared Peptide Binding Specificities Define Global Risk of Cotrimoxazole-induced SCAR
  2025 DOI: 10.1101/2025.05.28.25328237
  +Save